CDH2 and neoplasm: It can promote the expression of zeb1 in tumor cells, thereby inhibiting the expression of E-cadherin, and promoting N-cadherin and vimentin, contributing to cellular movement, and enhancing cancer epithelial-mesenchymal transition and movement [13, 14].